LifeTech Scientific Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	719.32	665.76	979.31	833.79	1,119
Short-Term Investments	29.78	205.13	80	-	158.11
Trading Asset Securities	401	311	120	-	199
Cash & Short-Term Investments	1,150	1,182	1,179	833.79	1,476
Cash Growth	-2.69%	0.22%	41.44%	-43.52%	29.20%
Accounts Receivable	161.8	136.69	105.19	137.09	110.04
Other Receivables	444.53	95.42	78.62	78.45	51.92
Receivables	606.33	232.11	183.81	215.54	161.96
Inventory	444.9	532.4	483.61	241.41	129.29
Other Current Assets	123.81	387.78	384.42	105.92	69.45
Total Current Assets	2,325	2,334	2,231	1,397	1,837
Property, Plant & Equipment	968.51	976.5	884.86	783.39	724.07
Long-Term Investments	505.53	421.94	531.71	725.5	48.63
Other Intangible Assets	779.18	70.25	75.15	84.42	76.07
Long-Term Deferred Tax Assets	125.58	117.14	83.03	62.6	47
Long-Term Deferred Charges	-	660.41	581.52	357.99	288.76
Other Long-Term Assets	308.5	319.96	308.95	279.56	162.12
Total Assets	5,012	4,900	4,696	3,690	3,184
Accounts Payable	84.7	59.54	124.09	62.65	30.76
Accrued Expenses	276.89	283.67	284.58	290.88	237.14
Current Portion of Leases	3.76	3.79	6.29	5.04	11.05
Current Income Taxes Payable	26.55	32.2	45.94	37.82	34.03
Current Unearned Revenue	34.57	26.09	12.5	13.17	11.43
Other Current Liabilities	1,053	410.34	296.74	175.18	157.51
Total Current Liabilities	1,479	815.64	770.14	584.74	481.91
Long-Term Leases	4.28	1.19	3	4.64	4.63
Long-Term Unearned Revenue	53.64	49.79	40.93	37.17	32.08
Other Long-Term Liabilities	-	558.33	558.33	142.5	135
Total Liabilities	1,537	1,425	1,372	769.05	653.61
Common Stock	0.04	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	1,632	1,643	1,628	1,621
Retained Earnings	-	1,925	1,702	1,439	1,114
Comprehensive Income & Other	3,513	-62.85	24.94	-166.88	-231.38
Total Common Equity	3,513	3,495	3,370	2,900	2,504
Minority Interest	-37.54	-19.08	-46.27	20.61	26.52
Shareholders' Equity	3,475	3,475	3,324	2,921	2,530
Total Liabilities & Equity	5,012	4,900	4,696	3,690	3,184
Total Debt	8.04	4.98	9.3	9.67	15.67
Net Cash (Debt)	1,142	1,177	1,170	824.12	1,461
Net Cash Growth	-2.96%	0.59%	41.97%	-43.58%	52.68%
Net Cash Per Share	0.26	0.27	0.26	0.19	0.32
Filing Date Shares Outstanding	4,632	4,631	4,630	4,630	4,630
Total Common Shares Outstanding	4,632	4,631	4,630	4,630	4,630
Working Capital	845.73	1,519	1,461	811.92	1,355
Book Value Per Share	0.76	0.75	0.73	0.63	0.54
Tangible Book Value	2,733	3,424	3,295	2,816	2,428
Tangible Book Value Per Share	0.59	0.74	0.71	0.61	0.52
Buildings	-	708.42	641.54	560.72	198.81
Machinery	-	337.97	306.4	262.72	265.59
Construction In Progress	-	122.79	76.04	55.31	325.06
Leasehold Improvements	-	33.62	30.57	28.61	20.44

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.